lifelong environment as to take a panoramic view of the conditions under which he has lived and moved ; it frees him from Plato's den long enough to see the realities as they are, the shadows as they appear." However little we may possess this rare and precious gift, any one of us may attempt to practise the art and undergo the experience of an interesting emancipation.
Thus to survey the panorama of acute rheumatism during the sixty years of its treatment by salicyl compounds is both impressive and depressing. It almost compels the utterance of a prayer that the orthodoxy of to-day may become the crime of to-morrow. It is an ascertained fact that, in spite of the use of salicylates, acute rheumatism is one of the deadliest of diseases. More children between the ages of eight and fifteen years die from heart disease than from any other single cause.1 Others suffer from intermittent invalidism, with the prospect of a brief maturity punctuated by attacks of heart failure of increasing severity and duration. Stroud found that of 307 cases followed up over a period of ten years, 123, or 40-7 per cent., had died or were totally disabled. 
ioi-2 3 weeks
In 9 of 16 cases in section 2, salicylates had failed after a lengthy trial. In 6 cases, salicylate had been given for not more than a week, and in the remaining one case it had been given for an unknown period. 
